Signal Advisors Wealth LLC increased its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 637.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,022 shares of the company's stock after purchasing an additional 17,308 shares during the quarter. Signal Advisors Wealth LLC's holdings in Colgate-Palmolive were worth $1,708,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in the business. TD Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 61.4% during the fourth quarter. TD Capital Management LLC now owns 326 shares of the company's stock worth $26,000 after purchasing an additional 124 shares during the period. Parvin Asset Management LLC bought a new position in shares of Colgate-Palmolive in the 2nd quarter worth about $32,000. Park Place Capital Corp boosted its holdings in shares of Colgate-Palmolive by 55.5% in the 2nd quarter. Park Place Capital Corp now owns 356 shares of the company's stock valued at $33,000 after buying an additional 127 shares during the period. Cherry Tree Wealth Management LLC boosted its holdings in shares of Colgate-Palmolive by 7,840.0% in the 2nd quarter. Cherry Tree Wealth Management LLC now owns 397 shares of the company's stock valued at $36,000 after buying an additional 392 shares during the period. Finally, Montgomery Financial Services LLC acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at about $36,000. Institutional investors and hedge funds own 80.41% of the company's stock.
Insider Transactions at Colgate-Palmolive
In related news, COO Panagiotis Tsourapas sold 10,000 shares of the stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the transaction, the chief operating officer directly owned 64,901 shares of the company's stock, valued at $5,974,137.05. This represents a 13.35% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director John Cahill sold 4,170 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the transaction, the director directly owned 28,373 shares of the company's stock, valued at $2,649,187.01. This trade represents a 12.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 175,191 shares of company stock worth $16,110,903. Company insiders own 0.43% of the company's stock.
Analyst Upgrades and Downgrades
CL has been the subject of a number of recent research reports. Barclays boosted their price objective on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 21st. Piper Sandler cut their target price on shares of Colgate-Palmolive from $98.00 to $95.00 and set an "overweight" rating on the stock in a report on Monday, September 21st. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $95.00 to $90.00 and set an "equal weight" rating for the company in a research note on Monday, October 5th. BNP Paribas Exane decreased their target price on Colgate-Palmolive from $101.00 to $97.00 and set an "outperform" rating for the company in a research note on Monday, September 28th. Finally, Bank of America lowered their target price on Colgate-Palmolive from $102.00 to $100.00 and set a "buy" rating for the company in a report on Friday, October 9th. Thirteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive has an average rating of "Moderate Buy" and a consensus target price of $98.11.
Read Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Trading Up 3.2%
Shares of NYSE:CL opened at $92.80 on Thursday. The company has a market cap of $73.98 billion, a PE ratio of 36.83, a P/E/G ratio of 4.30 and a beta of 0.33. The company's 50-day moving average price is $89.04 and its 200 day moving average price is $88.93. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The firm had revenue of $5.36 billion during the quarter, compared to analysts' expectations of $5.36 billion. During the same quarter in the prior year, the firm earned $0.92 EPS. Colgate-Palmolive's quarterly revenue was up 4.9% on a year-over-year basis. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.87 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be given a dividend of $0.53 per share. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. Colgate-Palmolive's payout ratio is currently 84.13%.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company NYSE: CL is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.
The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom's of Maine and Hill's Science Diet.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.